Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
AssigneePhilip Morris Products S.A.
InventorsStephane Demotz, Gerhard Lang, Damian McHugh, Axel Teichert, Fernando Goffman, Paul M. Doyle, Paul M. Blaney, Raymond Fisher, Andrew Smith, Emma L. Blaney, Simon Foster
Life of this patent
Estimating the term…
Abstract
Compounds of general formula (I), wherein A, Y, R1 and R2 are defined herein are useful in the treatment or prevention of proliferative diseases including cancer or infectious or parasitic diseases.
Claims32
A compound of general formula (I):
- wherein
- A is CH, N or NO,
- Y is H, methyl, ethyl or linear or branched lower alkyl with up to 4 carbon atoms, —CH2—O—C(═O)NH(lower alkyl) or —CH2—O—PO3H2,
- R1 is aryl or heteroaryl selected from nitrogen containing compounds and oxygen containing compounds optionally substituted by up to four substituents independently selected from:
- 1. halo,
- 2. C1-C6 alkyl,
- 3. C1-C6 haloalkyl,
- 4. C1-C6 alkoxy, (C1-C4 alkylene)OR3
- 5. C1-C6 haloalkoxy,
- 6. NHR3, (C1-C4 alkylene)NHR3, (C1-C4 alkylene)NR3R4,
- 7. NHC(O)R3, (C1-C4 alkylene)NHC(O)(C1-C6 alkyl),
- 8. C(O)NR3R4, (C1-C4 alkylene)C(O)NR3R4;
- 9. C(O)R3, (C1-C4 alkylene)C(O)R3;
- 10. C(O)O(C1-C6 alkyl), (C1-C4 alkylene)C(O)O(C1-C6 alkyl),
- 11. OC(O)(C1-C6 alkyl), (C1-C4 alkylene)OC(O)(C1-C6 alkyl),
- 12. OH, (C1-C4 alkylene)OH,
- 13. CN, (C1-C4 alkylene)CN,
- 14. aryl or heteroaryl selected from nitrogen containing compounds and oxygen containing compounds optionally substituted,
- 15. non-aromatic heterocyclic groups selected from nitrogen containing compounds, oxygen containing compounds and nitrogen and oxygen containing compounds optionally substituted,
- 16. NHC(O)NR3R4, (C1-C4 alkylene)NHC(O)NR3R4,
- 17. O(C1-C4 alkylene)OR3, (C1-C4 alkylene)O(C1-C4 alkylene)OR3,
- 18. NHS(O2)R3, (C1-C4 alkylene)NHS(O2)R3,
- 19. S(O2)NH2, S(O2)NHR3, S(O2)NR3R4,
- 20. S(O2)NH(C1-C4 alkylene)OH, S(O2)NH(C1-C4 alkylene)OR3,
- 21. C(O)NH(C1-C4 alkylene)OH, C(O)NH(C1-C4 alkylene)OR3,
- wherein each R3 and each R4 is independently H or C1-C6 alkyl;
- and
- wherein any of the suitable substituents for R1 described above may be substituted with one or more chloro or fluoro substitutents;
- R2 is linear or branched C1-C6 alkyl optionally substituted with F or Cl;
- or a pharmaceutically acceptable salt or solvate thereof;
- provided that
- if R1 is a phenyl group, it is not substituted by any of the substituents 1 to 12 or 14 to 21 at the 4-position,
- if R1 is a phenyl group, it is not substituted by any of the substituents 2 to 21 at the 2-position
- if R1 is an aryl, it is not a naphthalenyl group, anthracenyl or phenanthrenyl group,
- if R1 is an heteroaryl selected from nitrogen containing compounds, it is not a pyrimidinyl or a pyridazinyl group.
A compound according 19, wherein R1 is unsubstituted or has 1 to 4 substituents selected from the group consisting of:
- halo,
- C1-C4 alkyl,
- C1-C4 haloalkyl,
- C1-C4 alkoxy, (C1-C2 alkylene)OR3,
- C1-C4 haloalkoxy,
- NHR5, (C1-C2 alkylene)NHR5, (C1-C2 alkylene)NR5R6,
- NHC(O)R5, (C1-C2 alkylene)NHC(O)(C1-C4 alkyl),
- C(O)NR5R6, (C1-C2 alkylene)C(O)NR5R6;
- C(O)R5;
- (C1-C2 alkylene)C(O)R5;
- C(O)O(C1-C4 alkyl), (C1-C2 alkylene)C(O)O(C1-C4 alkyl),
- OC(O)(C1-C4 alkyl), (C1-C2 alkylene)OC(O)(C1-C4 alkyl),
- OH, (C1-C2 alkylene)OH,
- CN, (C1-C2 alkylene)CN, or
- aryl or heteroaryl selected from nitrogen containing compounds and oxygen containing compounds optionally substituted,
- non-aromatic heterocyclic groups selected from nitrogen containing compounds, oxygen containing compounds and nitrogen and oxygen containing compounds optionally substituted,
- NHC(O)NR5R6, (C1-C2 alkylene)NHC(O)NR5R6,
- O(C1-C2 alkylene)OR5, (C1-C2 alkylene)O(C1-C2 alkylene)OR5,
- NHS(O2)R5, (C1-C2 alkylene)NHS(O2)R5,
- S(O2)NH2, S(O2)NHR5, S(O2)NR5R6,
- S(O2)NH(C1-C2 alkylene)OH, S(O2)NH(C1-C2 alkylene)OR5,
- C(O)NH(C1-C2 alkylene)OH, C(O)NH(C1-C2 alkylene)OR3,
- wherein each R5 and each R6 is independently H or C1-C4 alkyl, and
- wherein any of the suitable substituents for R1 described above is optionally substituted with one or more chloro or fluoro substitutents.
A compound according 26, wherein R1 is unsubstituted or has 1 to 4 substituents selected from the group consisting of:
- halo,
- C1-C4 alkyl,
- C1-C4 haloalkyl,
- C1-C4 alkoxy, (C1-C2 alkylene)OR3,
- C1-C4 haloalkoxy,
- NHR5, (C1-C2 alkylene)NHR5, (C1-C2 alkylene)NR5R6,
- NHC(O)R5, (C1-C2 alkylene)NHC(O)(C1-C4 alkyl),
- C(O)NR5R6, (C1-C2 alkylene)C(O)NR5R6;
- C(O)R5;
- (C1-C2 alkylene)C(O)R5;
- C(O)O(C1-C4 alkyl), (C1-C2 alkylene)C(O)O(C1-C4 alkyl),
- OC(O)(C1-C4 alkyl), (C1-C2 alkylene)OC(O)(C1-C4 alkyl),
- OH, (C1-C2 alkylene)OH,
- CN, (C1-C2 alkylene)CN, or
- aryl or heteroaryl selected from nitrogen containing compounds and oxygen containing compounds optionally substituted,
- non-aromatic heterocyclic groups selected from nitrogen containing compounds, oxygen containing compounds and nitrogen and oxygen containing compounds optionally substituted,
- NHC(O)NR5R6, (C1-C2 alkylene)NHC(O)NR5R6,
- O(C1-C2 alkylene)OR5, (C1-C2 alkylene)O(C1-C2 alkylene)OR5,
- NHS(O2)R5, (C1-C2 alkylene)NHS(O2)R5,
- S(O2)NH2, S(O2)NHR5, S(O2)NR5R6,
- S(O2)NH(C1-C2 alkylene)OH, S(O2)NH(C1-C2 alkylene)OR5,
- C(O)NH(C1-C2 alkylene)OH, C(O)NH(C1-C2 alkylene)OR3,
- wherein each R5 and each R6 is independently H or C1-C4 alkyl, and
- wherein any of the suitable substituents for R1 described above is optionally substituted with one or more chloro or fluoro substitutents.
Dependencies are inferred from the claim text.